<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05029817</url>
  </required_header>
  <id_info>
    <org_study_id>HMO-0298-21</org_study_id>
    <nct_id>NCT05029817</nct_id>
  </id_info>
  <brief_title>Ovarian Reserve in Women With Cystic Fibrosis and the Correlation With Demographic and Clinical Parameters</brief_title>
  <official_title>Ovarian Reserve in Women With Cystic Fibrosis and the Correlation With Demographic and Clinical Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to assess the ovarian reserve of CF patients via&#xD;
      measurement of AMH and AFC. Secondly, we aim to correlate between the ovarian reserve and&#xD;
      demographic and clinical characteristics of these patients.&#xD;
&#xD;
      Outcomes measured will be levels of AMH and AFC, as compared to standard means in the general&#xD;
      population. There is no need for a control group in this study since the standardized means&#xD;
      of AMH and AFC in the general population are a more accurate comparable measure, which is&#xD;
      based on data collected from large-scale populations, and thus accounts for confounding age&#xD;
      factor in a more complete manner than can be obtained via a control group (Almog et al.,&#xD;
      2011, La Marca et al., 2012, Penzias et al., 2020).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>AMH levels</measure>
    <time_frame>24 hours</time_frame>
    <description>Levels of Anti-Mullerian hormone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Antral follicular count</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
    <description>Antral follicular count as assessed by ultrasound</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Infertility, Female</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Female CF patients seen regularly in the Hadassah Mt. Scopus CF Center, aged 18-45 years&#xD;
        old, who regularly attended the clinic, and from whom demographic and clinical parameters&#xD;
        are available.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female patients diagnosed with CF according to genetic testing.&#xD;
&#xD;
          -  Age 18-45 years old.&#xD;
&#xD;
          -  Routinely attended the CF Center at Hadassah Medical Center.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate in the study.&#xD;
&#xD;
          -  Age under 18 or above 45.&#xD;
&#xD;
          -  Use of hormonal contraceptives (for the purpose of AFC).&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anat Hershko Klement, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Keren Marks-Garber, MD</last_name>
    <phone>00 927 2 5844454</phone>
    <email>kerenmar@hadassah.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Organization, Jerusalem, Israel</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hadas Lemberg, PhD</last_name>
      <phone>00 972 2 6777572</phone>
      <email>lhadas@hadassah.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 21, 2021</study_first_submitted>
  <study_first_submitted_qc>August 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2021</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Antral follicular count</keyword>
  <keyword>Anti-Mullerian hormone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

